Group One Trading’s Atossa Therapeutics ATOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.6K Buy
8,000
+5,400
+208% +$12.9K ﹤0.01% 6052
2026
Q2
$5.02K Sell
2,600
-1,600
-38% -$7.29K ﹤0.01% 6736
2026
Q1
$22.1K Sell
4,200
-287
-6% -$1.82K ﹤0.01% 5898
2025
Q4
$39.7K Sell
4,487
-6,766
-60% -$85.6K ﹤0.01% 5784
2025
Q3
$146K Buy
11,253
+1,580
+16% +$19.5K ﹤0.01% 4985
2025
Q2
$120K Buy
9,673
+4,980
+106% +$59.5K ﹤0.01% 4805
2025
Q1
$47.4K Sell
4,693
-180
-4% -$2.18K ﹤0.01% 5208
2024
Q4
$69K Sell
4,873
-394
-7% -$7.69K ﹤0.01% 4819
2024
Q3
$120K Sell
5,267
-2,733
-34% -$55.2K ﹤0.01% 4022
2024
Q2
$143K Sell
8,000
-787
-9% -$17.4K ﹤0.01% 3673
2024
Q1
$237K Sell
8,787
-13,306
-60% -$214K ﹤0.01% 3411
2023
Q4
$292K Buy
22,093
+11,306
+105% +$122K ﹤0.01% 3529
2023
Q3
$119K Buy
10,787
+134
+1% +$1.94K ﹤0.01% 4293
2023
Q2
$201K Buy
10,653
+586
+6% +$7.11K ﹤0.01% 3919
2023
Q1
$109K Sell
10,067
-45,613
-82% -$509K ﹤0.01% 4234
2022
Q4
$441K Buy
55,680
+900
+2% +$10.3K ﹤0.01% 3157
2022
Q3
$685K Sell
54,780
-2,587
-5% -$37.6K ﹤0.01% 2925
2022
Q2
$938K Sell
57,367
-17,006
-23% -$268K ﹤0.01% 2815
2022
Q1
$1.4M Sell
74,373
-95,054
-56% -$1.93M ﹤0.01% 2756
2021
Q4
$4.07M Sell
169,427
-51,713
-23% -$1.89M ﹤0.01% 1891
2021
Q3
$10.8M Sell
221,140
-32,667
-13% -$1.9M 0.01% 1010
2021
Q2
$24.1M Buy
253,807
+118,967
+88% +$6.3M 0.03% 531
2021
Q1
$4.27M Buy
+134,840
New +$4.93M 0.01% 1685
2020
Q4
– Sell
-60
Closed -$2K – 6468
2020
Q3
$2K Hold
60
– – ﹤0.01% 5803
2020
Q2
$3K Buy
+60
New +$2.13K ﹤0.01% 5477

Other funds holding ATOS

Group One Trading's ATOS Position: Q3 2026 in Review

Group One Trading sold out of Atossa Therapeutics (ATOS) in Q3 2026, closing a stake of 54 shares — an estimated $129 sold.

Group One Trading first reported a position in ATOS in Q2 2019 and held it in 22 quarters. The position peaked at $10.4M in Q2 2021. 35 funds tracked by Wall St. Rank hold ATOS as of Q3 2026.

  • Group One Trading reported no remaining Atossa Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Group One Trading sold 54 Atossa Therapeutics shares in Q3 2026, an estimated $129.
  • Group One Trading first reported a position in Atossa Therapeutics in Q2 2019 and held it in 22 quarters.
  • Group One Trading's Atossa Therapeutics position peaked at $10.4M in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.